Issue 18, 2021

Establishment of primary reference measurement procedures and reference materials for EGFR variant detection in non-small cell lung cancer

Abstract

Circulating tumor DNA (ctDNA)-based mutation detection is promising to change the clinical practice of genotype-directed therapy for cancer. A growing number of non-invasive tests for cancer screening and monitoring that involve the detection of ctDNA have been commercialized. Primary reference measurement procedures (PRMPs) and reference materials (RMs) are urgently needed to assess the non-invasive tests. In this study, a PRMP based on digital PCR (dPCR) and ctDNA RMs for quantification of the frequently occurring variant in epidermal growth factor receptor (EGFR L858R, T790M, and 19Del) in non-small cell lung cancer (NSCLC) were established. The candidate dPCR PRMP showed high specificity (false positive rate 0–0.003%), good repeatability (coefficient of variance (CV), 2–3% for 104 copies/reaction), and high interlaboratory reproducibility (3–10%). A good linearity (0.97 < slope < 1.03, R2 ≥ 0.9999) between the measured mutant (MU) value and prepared value was observed for all assays over the fractional abundance (FA) range, between 25% and 0.05%. The limit of quantification (LoQ) was determined to be 34 L858R, 23 T790M, and 34 19Del copies/reaction, corresponding to a FA of 0.2%. An inter-laboratory study of using the EGFR ctDNA RMs and dPCR assays demonstrated that the participating laboratories produced consistent concentrations of MU and wild-type (WT), as well as FA. This study demonstrates that dPCR can act as a potential PRMP for EGFR mutation for validation of NSCLC genotyping tests and ctDNA quantitative tests. The PRMP and RMs established here could improve interlaboratory repeatability and reproducibility, which supports rapid translation and application of non-invasive tests into clinical practice.

Graphical abstract: Establishment of primary reference measurement procedures and reference materials for EGFR variant detection in non-small cell lung cancer

Supplementary files

Article information

Article type
Paper
Submitted
25 Feb 2021
Accepted
25 Mar 2021
First published
19 Apr 2021

Anal. Methods, 2021,13, 2114-2123

Establishment of primary reference measurement procedures and reference materials for EGFR variant detection in non-small cell lung cancer

X. Wang, Y. Zhang, C. Niu, S. Wang, L. Li, Y. Guo, L. Zhu, X. Jin, H. Gao, W. Xu, P. Zhu, Q. Lan, M. Du, X. Cheng, Y. Gao and L. Dong, Anal. Methods, 2021, 13, 2114 DOI: 10.1039/D1AY00328C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements